ScholarIQanswers from OpenAlex

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials

PaperCitations, authors & open-access status

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials have?

ScholarIQcitation count

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials has 58 citations in the OpenAlex counts ScholarIQ stores.

When was The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials published?

ScholarIQyear

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials has 2019 year in the ScholarIQ index.

What is the open-access status of The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials?

ScholarIQoa status

The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials has green oa status in the ScholarIQ index.

What is the DOI of The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials?

ScholarIQdoi

The DOI for The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials is on the source record.

What is the PMID of The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials?

ScholarIQpmid

The PMID for The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials is on the source record.

What is the OpenAlex record for The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials?

ScholarIQopenalex

The OpenAlex for The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial